- Exploring strategies for enhancing efficiency and reliability in the supply chain for cell therapy products, encompassing supply/demand planning, strategic sourcing, GMP purchasing, and external manufacturing
- Delving into the evolution of manufacturing methodologies, focusing on cutting-edge technologies, automation, and adaptive processes to meet increasing demands and regulatory requirements
- Discussing best practices, challenges, and considerations in establishing and managing facilities on a global scale, addressing regulatory compliance, operational excellence, and localization strategies
- Highlighting innovative approaches to managing the drug supply chain, from clinical trials to commercialization, including advancements in logistics, temperature-controlled distribution, and risk mitigation strategies
Craig Beasley
Chief Technical Officer
BlueRock Therapeutics
Craig Beasley joined BlueRock Therapeutics in August 2021. As Chief Technology Officer he is responsible for Technical Operations including cell line derivation, process development, manufacturing, facilities and engineering, lab operations, and analytical sciences.
Prior to BlueRock, Craig served as VP, Cell Therapy Supply Chain and Patient Operations at BMS overseeing cell therapy assets (clinical and commercial stage), demand and supply planning, patient operations, external manufacturing oversight (including oversight for lentiviral vector manufacturing), materials management, cell logistics and Cell Therapy’s Business Process owners.
Craig joined Juno Therapeutics in 2016 as head of manufacturing & supply chain.
Prior to that Craig was VP, Next Generation Manufacturing at Biogen, holding leadership positions throughout the technical operations group. Craig started Biogen leading the Process & Automation engineering group and then transferred to the Director of Manufacturing for Biogen’s RTP large scale manufacturing facility. Further to that, Craig served as head of Supply Chain Quality and in addition, worked as Vice President of Financial Planning and Analysis for 2 years reporting to the CFO.
Craig holds a B.S. in Chemical Engineering from Purdue University.
